Inactive Instrument

Insiders Vifor Pharma London S.E.

Equities

0RPD

CH0364749348

Insiders

Unlock all the news: Be the first to know and act before the market!

Rhythm Biosciences Expands Executive Management Team, Registers Diagnostic Blood Test With New Zealand	03/11/22	MT
Vifor Pharma Announces Resignation of Abbas Hussain as CEO	02/08/22	CI
Landos Biopharma Appoints Gregory Oakes Chief Executive Officer	21/06/22	MT
Vifor Pharma Ag Announces Board Changes	26/04/22	CI
Vifor Pharma Group Appoints Two New Members to the Executive Committee	02/02/22	CI
Vifor Pharma Appoints GlaxoSmithKline Executive As Chief Commercial Officer	13/12/21	MT
Vifor Pharma Appoints Hervé Gisserot as Chief Commercial Officer and Member of the Executive Committee, Effective 17 January 2022	10/12/21	CI
Vifor Pharma CFO To Retire In December	30/11/21	MT
Vifor Pharma Announces Changes to its Executive Committee	12/10/21	CI
Vifor Pharma : Appoints Former GlaxoSmithKline Executive as CEO; Shares Down 5%	25/06/21	MT
Vifor Pharma : Abbas Hussain Appointed as New Chief Executive Officer of Vifor Pharma	24/06/21	BU
Vifor Pharma Group Announces Chief Executive Officer Changes	24/06/21	CI
Vifor Pharma AG Announces Director Changes	06/05/21	CI
Vifor Pharma Announces Board Changes	02/02/21	CI
Vifor Pharma Announces Board Changes	02/09/20	CI
Vifor Pharma AG Approves Dividend, Payable on 20 May 2020; Announces Board Changes	14/05/20	CI
Vifor Pharma AG Announces Management Changes	12/03/20	CI
Vifor Pharma Appoints Lee Heeson as President International and Member of the Executive Committee, Effective February 1, 2020	18/11/19	CI
Vifor Pharma Reorganizes its Management Team	21/09/19	CI
Vifor Pharma Announces Management Changes	11/09/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Vifor Pharma London S.E.

Equities

0RPD

CH0364749348

Insiders

Filters